Artelo Biosciences, Inc. (ARTL)
Largest Insider Buys in Sector
ARTL Stock Price History Chart
ARTL Stock Performance
About Artelo Biosciences, Inc.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for …
Insider Activity of Artelo Biosciences, Inc.
Over the last 12 months, insiders at Artelo Biosciences, Inc. have bought $0 and sold $0 worth of Artelo Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Artelo Biosciences, Inc. have bought $26,506 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,200 shares for transaction amount of $4,800 was made by Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) on 2022‑08‑12.
List of Insider Buy and Sell Transactions, Artelo Biosciences, Inc.
| 2022-08-12 | Pres, CEO, CFO, Treas & Secr | 1,200 0.0445% | $4.00 | $4,800 | -27.57% | |||
| 2022-08-11 | Pres, CEO, CFO, Treas & Secr | 1,200 0.0456% | $4.03 | $4,836 | -26.01% | |||
| 2021-04-16 | Pres, CEO, CFO, Treas & Secr | 8,500 0.0366% | $1.15 | $9,809 | -30.82% | |||
| 2020-05-15 | Pres, CEO, CFO, Treas & Secr | 4,200 0.1219% | $1.21 | $5,072 | -5.00% | |||
| 2020-05-04 | Pres, CEO, CFO, Treas & Secr | 4,167 0.1136% | $1.20 | $5,000 | -9.45% | |||
| 2020-05-04 | director | 41,667 1.1357% | $1.20 | $50,000 | -9.45% | |||
| 2019-11-04 | Pres, CEO, CFO, Treas & Secr | 2,400 0.0701% | $2.21 | $5,304 | -45.78% | |||
| 2019-11-01 | Pres, CEO, CFO, Treas & Secr | 2,500 0.0823% | $2.28 | $5,702 | -40.29% | |||
| 2019-10-31 | Pres, CEO, CFO, Treas & Secr | 2,500 0.0729% | $1.95 | $4,875 | -38.19% | |||
| 2019-10-30 | Pres, CEO, CFO, Treas & Secr | 2,600 0.0771% | $1.99 | $5,186 | -38.50% | |||
| 2019-10-15 | Pres, CEO, CFO, Treas & Secr | 2,600 0.0793% | $2.05 | $5,333 | -37.50% | |||
| 2019-10-11 | Pres, CEO, CFO, Treas & Secr | 2,700 0.0796% | $1.96 | $5,296 | -36.87% |
Insider Historical Profitability
| MATSUI CONNIE | director | 56667 1.7556% | $0.97 | 1 | 0 | <0.0001% |
| Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2400 0.0744% | $0.97 | 11 | 0 | <0.0001% |